Milestone Pharmaceuticals
MIST
28 hedge funds and large institutions have $111M invested in Milestone Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.
425% more call options, than puts
Call options by funds: $2.19M | Put options by funds: $416K
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.52% less ownership
Funds ownership: 68.03% → 67.5% (-0.52%)
6% less capital invested
Capital invested by funds: $117M → $111M (-$6.63M)
18% less funds holding
Funds holding: 34 → 28 (-6)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| 1 |
PVI
Pura Vida Investments
New York
|
+$1.33M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$816K |
| 3 |
Barclays
London,
United Kingdom
|
+$267K |
| 4 |
Morgan Stanley
New York
|
+$194K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$93.2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | -$590 | -104 | -34% |
|
|
CFGS
27
Concourse Financial Group Securities
Birmingham,
Alabama
| $1K | – | – | – |
|
28
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$1.55M | -267,997 | Closed |
|
|
JGC
29
J. Goldman & Co
New York
| – | -$581K | -100,283 | Closed |
|
30
California Public Employees Retirement System
Sacramento,
California
| – | -$290K | -50,100 | Closed |
|
31
TD Asset Management
Toronto,
Ontario, Canada
| – | -$108K | -18,704 | Closed |
|
|
CAC
32
Cowen and Company
New York
| – | -$30K | -5,166 | Closed |
|
|
SFS
33
Sowell Financial Services
North Little Rock,
Arkansas
| – | -$8K | -1,440 | Closed |
|
|
WAP
34
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| – | -$2K | -352 | Closed |
|
MIST Hedge Fund Activity: Q2 2021 in Review
28 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q2 2021, worth a combined $111M — down 5.6% from $117M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MIST and 2 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 8 added.
The largest buyer was Pura Vida Investments, adding an estimated $1.33M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $1.55M sold.
- 28 institutional investors held Milestone Pharmaceuticals (MIST) as of Q2 2021, down from 34 in Q1 2021.
- Funds reported $111M of Milestone Pharmaceuticals stock for Q2 2021, down 5.6% quarter-over-quarter.
- 2 funds opened new Milestone Pharmaceuticals positions in Q2 2021 and 8 closed out, a net change of -6 holders.
- The largest Milestone Pharmaceuticals buyer in Q2 2021 was Pura Vida Investments, an estimated $1.33M added.
- The largest Milestone Pharmaceuticals seller in Q2 2021 was T. Rowe Price Associates, an estimated $1.55M sold.
Based on aggregated 13F filings for Q2 2021.